Histone methyltransferase DOT1L maintains cell state and restricts cytotoxic potential of CD8 T cells.

Malik, Muddassir; de Leeuw, Willem-Jan; Aslam, Muhammad Assad; Kwesi-Maliepaard, Eliza Mari; van den Brand, Teun; van den Broek, Bram; Kempers, Maxime; Hoekman, Liesbeth et al. · Sci Adv · 2025

basic_science · Level V

Where this comes from

Abstract

The histone methyltransferase DOT1L is emerging as a central epigenetic regulator in immune cells. Loss of DOT1L during development of CD8 T cells in vivo leads to gain of memory characteristics but has also been reported to compromise CD8 T cell viability and antitumor reactivity. Here, we determined the cell-intrinsic role of DOT1L in mature mouse CD8 T cells. After conditional deletion of <i>Dot1L</i> in vitro, CD8 T cells retained in vivo proliferative capacity and antitumor reactivity. Moreover, <i>Dot1L</i> knockout CD8 T cells showed increased antigen-specific cytotoxicity toward tumor cells in vitro. Mechanistically, loss of DOT1L resulted in an altered cell state with loss of T cell and gain of innate-like features. These transcriptional changes were mediated by loss of DOT1L methyltransferase activity in a dose-dependent manner. Our findings show that in mature CD8 T cells, ablation of DOT1L activity is well tolerated and reprograms them to gain innate-like memory cell characteristics and enhance intrinsic cytotoxic capacity.

Medical subject headings